Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

rizatriptan

Known as: rizatriptan [Chemical/Ingredient], Rizatriptán, N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
The study aims to provide an updated assessment of the evidence for individual pharmacological therapies for acute migraine… Expand
Highly Cited
2014
Highly Cited
2014
In 459 migraine attacks, information provided to patients (from negative to neutral to positive) modified placebo and medication… Expand
Highly Cited
2008
Highly Cited
2008
Objective: To determine an effective and tolerable dose of a novel oral calcitonin gene-related peptide (CGRP) receptor… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Review
2004
Review
2004
Objective: To review evidence on the pharmacologic treatment of the child with migraine headache. Methods: The authors reviewed… Expand
  • table 1
  • table 2
  • table 3
Review
2003
Review
2003
Background and Objectives.—Triptan use is associated with headache recurrence, and this has been cited as an important reason for… Expand
Review
2002
Review
2002
The triptans, selective serotonin 5-HT1B/1D agonists, are very effective acute migraine drugs. Soon, seven different triptans… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Highly Cited
2001
Highly Cited
2001
BACKGROUND The triptans, selective serotonin 5-HT(1B/1D) agonists, are very effective acute migraine drugs with a well- developed… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1998
Highly Cited
1998
Rizatriptan is a potent, oral, 5‐HT1B/1D agonist with more rapid absorption and higher bioavailability than oral sumatriptan. It… Expand
Highly Cited
1997
Highly Cited
1997
These studies in anaesthetised rats showed, using intravital microscopy, that the novel anti-migraine agent, rizatriptan… Expand
Highly Cited
1996
Highly Cited
1996
BACKGROUND Rizatriptan (MK-462) is a new 5-hydroxytryptamine1D (serotonin1D; 5-HT1D) receptor agonist for the acute treatment of… Expand